Have a feature idea you'd love to see implemented?
Let us know!
Price (delayed)
$107.81
Market cap
$21.96B
P/E Ratio
22.37
Dividend/share
$0.96
EPS
$4.82
Enterprise value
$27.37B
Zimmer Biomet is a publicly traded medical device company. It was founded in 1927 to produce aluminum splints. The firm is headquartered in Warsaw, Indiana, where it is part of
Highlights
The EPS has soared by 101% YoY and by 3.9% from the previous quarter
The net income has surged by 97% year-on-year and by 3.4% since the previous quarter
ZBH's quick ratio is down by 33% YoY and by 23% QoQ
The debt has increased by 2.2% year-on-year
Key stats
What are the main financial stats of ZBH
Market
Valuations
Earnings
Shares outstanding
203.65M
Market cap
$21.96B
Enterprise value
$27.37B
Price to earnings (P/E)
22.37
Price to book (P/B)
1.74
Price to sales (P/S)
2.95
EV/EBIT
22.38
EV/EBITDA
12.51
EV/Sales
3.64
Revenue
$7.52B
EBIT
$1.22B
EBITDA
$2.19B
Free cash flow
$964.8M
Per share
Balance sheet
Liquidity
EPS
$4.82
Free cash flow per share
$4.69
Book value per share
$61.93
Revenue per share
$36.58
TBVPS
$38.83
Total assets
$21.52B
Total liabilities
$8.77B
Debt
$5.83B
Equity
$12.74B
Working capital
$1.03B
Debt to equity
0.46
Current ratio
1.29
Quick ratio
0.51
Net debt/EBITDA
2.48
Margins
Efficiency
Dividend
EBITDA margin
29.1%
Gross margin
71.8%
Net margin
13.3%
Operating margin
16.5%
Return on assets
4.7%
Return on equity
7.9%
Return on invested capital
11.8%
Return on capital employed
6.8%
Return on sales
16.3%
Dividend yield
0.89%
DPS
$0.96
Payout ratio
19.9%
ZBH stock price
How has the Zimmer Biomet Holdings stock price performed over time
Intraday
3.78%
1 week
2.97%
1 month
-0.13%
1 year
4.25%
YTD
-11.41%
QTD
-0.13%
Financial performance
How have Zimmer Biomet Holdings's revenue and profit performed over time
Revenue
$7.52B
Gross profit
$5.4B
Operating income
$1.24B
Net income
$997.1M
Gross margin
71.8%
Net margin
13.3%
The net income has surged by 97% year-on-year and by 3.4% since the previous quarter
The net margin has surged by 90% year-on-year and by 3.1% since the previous quarter
Zimmer Biomet Holdings's operating income has increased by 42% YoY
Zimmer Biomet Holdings's operating margin has increased by 36% YoY
Growth
What is Zimmer Biomet Holdings's growth rate over time
Valuation
What is Zimmer Biomet Holdings stock price valuation
P/E
22.37
P/B
1.74
P/S
2.95
EV/EBIT
22.38
EV/EBITDA
12.51
EV/Sales
3.64
The EPS has soared by 101% YoY and by 3.9% from the previous quarter
ZBH's P/E is 76% lower than its 5-year quarterly average of 90.3 and 31% lower than its last 4 quarters average of 31.4
The stock's P/B is 24% below its 5-year quarterly average of 2.2 and 16% below its last 4 quarters average of 2.0
ZBH's equity is up by 3% year-on-year
ZBH's price to sales (P/S) is 27% lower than its 5-year quarterly average of 3.9 and 14% lower than its last 4 quarters average of 3.3
The revenue has grown by 4.6% YoY
Efficiency
How efficient is Zimmer Biomet Holdings business performance
The ROA has soared by 96% YoY and by 4.4% from the previous quarter
Zimmer Biomet Holdings's return on equity has surged by 93% YoY and by 2.6% QoQ
The ROIC has increased by 46% YoY and by 4.4% QoQ
The ROS has grown by 38% YoY
Dividends
What is ZBH's dividend history
DPS
$0.96
Dividend yield
0.89%
Payout ratio
19.9%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Zimmer Biomet Holdings financials performed over time
The total assets is 145% higher than the total liabilities
The current ratio has contracted by 34% YoY and by 22% from the previous quarter
ZBH's quick ratio is down by 33% YoY and by 23% QoQ
The debt is 54% smaller than the equity
ZBH's equity is up by 3% year-on-year
The debt has increased by 2.2% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.